Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
At close: Nov 4, 2024, 4:00 PM
0.940
-0.060 (-6.00%)
Pre-market: Nov 5, 2024, 5:17 AM EST
Biofrontera Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -13.51 | -20.13 | -0.64 | -37.71 | -10.99 | -10.98 |
Depreciation & Amortization | 1.16 | 1.06 | 1.17 | 0.54 | 0.56 | 0.67 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.59 |
Loss (Gain) From Sale of Investments | 3.01 | 7.42 | -1.75 | - | - | - |
Stock-Based Compensation | 0.87 | 1.05 | 1.85 | 0.13 | - | - |
Provision & Write-off of Bad Debts | 0.14 | 0.12 | 0.11 | 0.04 | -0.02 | 0.05 |
Other Operating Activities | -10.16 | -10.02 | -19.73 | 11.79 | 0.9 | -4.06 |
Change in Accounts Receivable | -1.45 | -1.54 | -0.07 | -0.61 | 1.17 | -0.76 |
Change in Inventory | 10.83 | -3.75 | -2.81 | 2.59 | -0.27 | -3.54 |
Change in Accounts Payable | -1.3 | 6.42 | 0.91 | -0.77 | -3.4 | 1.44 |
Change in Other Net Operating Assets | -8.51 | -5.52 | 4.76 | -2.71 | -0.32 | -21.08 |
Operating Cash Flow | -18.92 | -24.9 | -16.2 | -26.72 | -12.37 | -37.68 |
Capital Expenditures | - | -0.01 | -0.04 | -0.01 | - | -0.54 |
Cash Acquisitions | - | - | - | - | - | 25.93 |
Investment in Securities | 0.5 | 0.62 | -5.12 | - | - | - |
Investing Cash Flow | 0.45 | 0.62 | -5.16 | -0.01 | - | 25.4 |
Short-Term Debt Issued | - | 25.25 | - | - | - | - |
Long-Term Debt Issued | - | - | - | - | 8.79 | 13.5 |
Total Debt Issued | 19.55 | 25.25 | - | - | 8.79 | 13.5 |
Short-Term Debt Repaid | - | -21.34 | - | - | - | - |
Total Debt Repaid | -20.77 | -21.34 | - | - | - | - |
Net Debt Issued (Repaid) | -1.22 | 3.9 | - | - | 8.79 | 13.5 |
Issuance of Common Stock | 19.61 | 4.51 | 14.02 | 43.19 | - | - |
Other Financing Activities | - | - | - | - | 4.4 | 2.9 |
Financing Cash Flow | 18.39 | 8.41 | 14.02 | 43.19 | 13.19 | 16.4 |
Net Cash Flow | -0.07 | -15.87 | -7.33 | 16.47 | 0.83 | 4.12 |
Free Cash Flow | -18.92 | -24.9 | -16.24 | -26.73 | -12.37 | -38.22 |
Free Cash Flow Margin | -53.67% | -73.08% | -56.63% | -110.90% | -65.62% | -145.96% |
Free Cash Flow Per Share | -6.21 | -16.10 | -15.36 | -60.68 | - | - |
Cash Interest Paid | 1.87 | 0.15 | 0 | 0 | 3.07 | 1.71 |
Cash Income Tax Paid | 0.02 | 0.02 | 0.03 | 0.06 | 0.06 | 0.05 |
Levered Free Cash Flow | -17.96 | -24.79 | 2.36 | -9.66 | -9.11 | - |
Unlevered Free Cash Flow | -16.45 | -24.41 | 2.59 | -9.43 | -7.3 | - |
Change in Net Working Capital | 6.66 | 13.17 | -13.05 | 0.96 | 2.65 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.